Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital
Fecal specimens from children presenting to Texas Children's Hospital with acute gastroenteritis were tested for the presence of rotavirus. Children were grouped according to vaccination status, and pentavalent rotavirus vaccine effectiveness was calculated. Pentavalent rotavirus vaccine effect...
Gespeichert in:
| Veröffentlicht in: | The Pediatric infectious disease journal 2010-12, Vol.29 (12), p.1133-1135 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1135 |
|---|---|
| container_issue | 12 |
| container_start_page | 1133 |
| container_title | The Pediatric infectious disease journal |
| container_volume | 29 |
| creator | Boom, Julie A Tate, Jacqueline E Sahni, Leila C Rench, Marcia A Quaye, Osbourne Mijatovic-Rustempasic, Slavica Patel, Manish M Baker, Carol J Parashar, Umesh D |
| description | Fecal specimens from children presenting to Texas Children's Hospital with acute gastroenteritis were tested for the presence of rotavirus. Children were grouped according to vaccination status, and pentavalent rotavirus vaccine effectiveness was calculated. Pentavalent rotavirus vaccine effectiveness against severe rotavirus gastroenteritis was sustained during the first 2 years of the vaccination program. Overall 3-dose effectiveness was 83% to 86%; it was 92% to 93% among children 6 to 11 months of age and 78% to 84% among children ≥12 months of age. |
| doi_str_mv | 10.1097/INF.0b013e3181ed18ab |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_812133191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>812133191</sourcerecordid><originalsourceid>FETCH-LOGICAL-p210t-1cb9f50b2de88f9e6ce7b868ddab87547777b575a7b1322f4a2ad93e2c5688c43</originalsourceid><addsrcrecordid>eNo1kE1LxDAYhIMgun78A5HcvNg1H22THkVcFUQPq-fyJnmrkW5ak3TBH-F_tuh6msM8zDBDyBlnS84adfXwtFoyw7hEyTVHxzWYPbLglRQFa7Q6JEcpfTDGZMnZATkUrJalUvWCfK-nlMEHdHSMQ0ab_RBoF4cNHTFk2EI_C50t2Po4JboFa32AX8xN0Yc3mt-RJrRDcPQLIdKho73vkEKmQHuIb3hJp2gg0Nfg89y0zpAxzQXOQ47e0vchjT5Df0L2O-gTnu70mLyubl9u7ovH57uHm-vHYhSc5YJb03QVM8Kh1l2DtUVldK2dA6NVNS9TylSqAmW4FKIrQYBrJApb1VrbUh6Ti7_cefPnhCm3G58s9j0EHKbUai64lLzhM3m-IyezQdeO0W8gfrX_D8ofxKR2Sw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>812133191</pqid></control><display><type>article</type><title>Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Boom, Julie A ; Tate, Jacqueline E ; Sahni, Leila C ; Rench, Marcia A ; Quaye, Osbourne ; Mijatovic-Rustempasic, Slavica ; Patel, Manish M ; Baker, Carol J ; Parashar, Umesh D</creator><creatorcontrib>Boom, Julie A ; Tate, Jacqueline E ; Sahni, Leila C ; Rench, Marcia A ; Quaye, Osbourne ; Mijatovic-Rustempasic, Slavica ; Patel, Manish M ; Baker, Carol J ; Parashar, Umesh D</creatorcontrib><description>Fecal specimens from children presenting to Texas Children's Hospital with acute gastroenteritis were tested for the presence of rotavirus. Children were grouped according to vaccination status, and pentavalent rotavirus vaccine effectiveness was calculated. Pentavalent rotavirus vaccine effectiveness against severe rotavirus gastroenteritis was sustained during the first 2 years of the vaccination program. Overall 3-dose effectiveness was 83% to 86%; it was 92% to 93% among children 6 to 11 months of age and 78% to 84% among children ≥12 months of age.</description><identifier>EISSN: 1532-0987</identifier><identifier>DOI: 10.1097/INF.0b013e3181ed18ab</identifier><identifier>PMID: 20634776</identifier><language>eng</language><publisher>United States</publisher><subject>Age Factors ; Feces - virology ; Gastroenteritis - epidemiology ; Gastroenteritis - prevention & control ; Gastroenteritis - virology ; Hospitals, Pediatric ; Humans ; Infant ; Infant, Newborn ; Rotavirus Infections - epidemiology ; Rotavirus Infections - immunology ; Rotavirus Infections - prevention & control ; Rotavirus Vaccines - immunology ; Texas ; Urban Population ; Vaccines, Attenuated - immunology</subject><ispartof>The Pediatric infectious disease journal, 2010-12, Vol.29 (12), p.1133-1135</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20634776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boom, Julie A</creatorcontrib><creatorcontrib>Tate, Jacqueline E</creatorcontrib><creatorcontrib>Sahni, Leila C</creatorcontrib><creatorcontrib>Rench, Marcia A</creatorcontrib><creatorcontrib>Quaye, Osbourne</creatorcontrib><creatorcontrib>Mijatovic-Rustempasic, Slavica</creatorcontrib><creatorcontrib>Patel, Manish M</creatorcontrib><creatorcontrib>Baker, Carol J</creatorcontrib><creatorcontrib>Parashar, Umesh D</creatorcontrib><title>Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital</title><title>The Pediatric infectious disease journal</title><addtitle>Pediatr Infect Dis J</addtitle><description>Fecal specimens from children presenting to Texas Children's Hospital with acute gastroenteritis were tested for the presence of rotavirus. Children were grouped according to vaccination status, and pentavalent rotavirus vaccine effectiveness was calculated. Pentavalent rotavirus vaccine effectiveness against severe rotavirus gastroenteritis was sustained during the first 2 years of the vaccination program. Overall 3-dose effectiveness was 83% to 86%; it was 92% to 93% among children 6 to 11 months of age and 78% to 84% among children ≥12 months of age.</description><subject>Age Factors</subject><subject>Feces - virology</subject><subject>Gastroenteritis - epidemiology</subject><subject>Gastroenteritis - prevention & control</subject><subject>Gastroenteritis - virology</subject><subject>Hospitals, Pediatric</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Rotavirus Infections - epidemiology</subject><subject>Rotavirus Infections - immunology</subject><subject>Rotavirus Infections - prevention & control</subject><subject>Rotavirus Vaccines - immunology</subject><subject>Texas</subject><subject>Urban Population</subject><subject>Vaccines, Attenuated - immunology</subject><issn>1532-0987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1LxDAYhIMgun78A5HcvNg1H22THkVcFUQPq-fyJnmrkW5ak3TBH-F_tuh6msM8zDBDyBlnS84adfXwtFoyw7hEyTVHxzWYPbLglRQFa7Q6JEcpfTDGZMnZATkUrJalUvWCfK-nlMEHdHSMQ0ab_RBoF4cNHTFk2EI_C50t2Po4JboFa32AX8xN0Yc3mt-RJrRDcPQLIdKho73vkEKmQHuIb3hJp2gg0Nfg89y0zpAxzQXOQ47e0vchjT5Df0L2O-gTnu70mLyubl9u7ovH57uHm-vHYhSc5YJb03QVM8Kh1l2DtUVldK2dA6NVNS9TylSqAmW4FKIrQYBrJApb1VrbUh6Ti7_cefPnhCm3G58s9j0EHKbUai64lLzhM3m-IyezQdeO0W8gfrX_D8ofxKR2Sw</recordid><startdate>201012</startdate><enddate>201012</enddate><creator>Boom, Julie A</creator><creator>Tate, Jacqueline E</creator><creator>Sahni, Leila C</creator><creator>Rench, Marcia A</creator><creator>Quaye, Osbourne</creator><creator>Mijatovic-Rustempasic, Slavica</creator><creator>Patel, Manish M</creator><creator>Baker, Carol J</creator><creator>Parashar, Umesh D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201012</creationdate><title>Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital</title><author>Boom, Julie A ; Tate, Jacqueline E ; Sahni, Leila C ; Rench, Marcia A ; Quaye, Osbourne ; Mijatovic-Rustempasic, Slavica ; Patel, Manish M ; Baker, Carol J ; Parashar, Umesh D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p210t-1cb9f50b2de88f9e6ce7b868ddab87547777b575a7b1322f4a2ad93e2c5688c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Age Factors</topic><topic>Feces - virology</topic><topic>Gastroenteritis - epidemiology</topic><topic>Gastroenteritis - prevention & control</topic><topic>Gastroenteritis - virology</topic><topic>Hospitals, Pediatric</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Rotavirus Infections - epidemiology</topic><topic>Rotavirus Infections - immunology</topic><topic>Rotavirus Infections - prevention & control</topic><topic>Rotavirus Vaccines - immunology</topic><topic>Texas</topic><topic>Urban Population</topic><topic>Vaccines, Attenuated - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boom, Julie A</creatorcontrib><creatorcontrib>Tate, Jacqueline E</creatorcontrib><creatorcontrib>Sahni, Leila C</creatorcontrib><creatorcontrib>Rench, Marcia A</creatorcontrib><creatorcontrib>Quaye, Osbourne</creatorcontrib><creatorcontrib>Mijatovic-Rustempasic, Slavica</creatorcontrib><creatorcontrib>Patel, Manish M</creatorcontrib><creatorcontrib>Baker, Carol J</creatorcontrib><creatorcontrib>Parashar, Umesh D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The Pediatric infectious disease journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boom, Julie A</au><au>Tate, Jacqueline E</au><au>Sahni, Leila C</au><au>Rench, Marcia A</au><au>Quaye, Osbourne</au><au>Mijatovic-Rustempasic, Slavica</au><au>Patel, Manish M</au><au>Baker, Carol J</au><au>Parashar, Umesh D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital</atitle><jtitle>The Pediatric infectious disease journal</jtitle><addtitle>Pediatr Infect Dis J</addtitle><date>2010-12</date><risdate>2010</risdate><volume>29</volume><issue>12</issue><spage>1133</spage><epage>1135</epage><pages>1133-1135</pages><eissn>1532-0987</eissn><abstract>Fecal specimens from children presenting to Texas Children's Hospital with acute gastroenteritis were tested for the presence of rotavirus. Children were grouped according to vaccination status, and pentavalent rotavirus vaccine effectiveness was calculated. Pentavalent rotavirus vaccine effectiveness against severe rotavirus gastroenteritis was sustained during the first 2 years of the vaccination program. Overall 3-dose effectiveness was 83% to 86%; it was 92% to 93% among children 6 to 11 months of age and 78% to 84% among children ≥12 months of age.</abstract><cop>United States</cop><pmid>20634776</pmid><doi>10.1097/INF.0b013e3181ed18ab</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1532-0987 |
| ispartof | The Pediatric infectious disease journal, 2010-12, Vol.29 (12), p.1133-1135 |
| issn | 1532-0987 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_812133191 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Age Factors Feces - virology Gastroenteritis - epidemiology Gastroenteritis - prevention & control Gastroenteritis - virology Hospitals, Pediatric Humans Infant Infant, Newborn Rotavirus Infections - epidemiology Rotavirus Infections - immunology Rotavirus Infections - prevention & control Rotavirus Vaccines - immunology Texas Urban Population Vaccines, Attenuated - immunology |
| title | Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T18%3A29%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sustained%20protection%20from%20pentavalent%20rotavirus%20vaccination%20during%20the%20second%20year%20of%20life%20at%20a%20large,%20urban%20United%20States%20pediatric%20hospital&rft.jtitle=The%20Pediatric%20infectious%20disease%20journal&rft.au=Boom,%20Julie%20A&rft.date=2010-12&rft.volume=29&rft.issue=12&rft.spage=1133&rft.epage=1135&rft.pages=1133-1135&rft.eissn=1532-0987&rft_id=info:doi/10.1097/INF.0b013e3181ed18ab&rft_dat=%3Cproquest_pubme%3E812133191%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=812133191&rft_id=info:pmid/20634776&rfr_iscdi=true |